Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Apr 8, 2026 (6 months ago)

Fungal Fusion ERADICATION Solution

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry

Cause type: Stability / shelf life

The product degraded or failed stability testing before its labeled expiry. Heat, moisture or time can break the drug down into degradants or reduce potency. All stability / shelf life recalls.

What was recalled

Fungal Fusion ERADICATION Solution, Antifungal & Antimicrobial Kit. Contains, 1x2 oz bottle Fungal Fusion Antifungal (Miconazole Nitrate) Cream, 1x2oz bottle Fungal Fusion Antifungal Solution (25% Undecylenic Acid) and 1x1oz bottle of Fungal Fusion Eradication Antimicrobial Show Spray (isopropyl Alcohol, D-Limonene, Undecylenic Acid). Manufactured By: Blaine Labs, Inc., 11037 Lockport Place, Santa Fe Springs, CA 90670, Manufactured for Doctor's Inc

Drug: Alcohol

Recalling firm
Blaine Labs Inc
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0698-2026 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other Alcohol recalls

See all

Other recalls by Blaine Labs Inc

All 2026 recalls
Class II · Moderate risk

Revitaderm Wound Care

CGMP Deviations; product manufactured in the same facility under the same conditions as the product found to be contaminated

Ongoing cGMP deviation Blaine Labs Inc NDC 63347-120-02 D-0699-2026
Class II · Moderate risk

vite20 Antifungal Cream

CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry

Ongoing Stability / shelf life Blaine Labs Inc D-0696-2026
Class II · Moderate risk

TERPENICOL Antifungal Cream

CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry

Ongoing Stability / shelf life Blaine Labs Inc NDC 63347-601-01 D-0695-2026